Skip to content

Updates

Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.

Data Protection, (Cyber)security and AI Testimonial

We have created the data protection strategy for a long-term registry study.

Medical Devices Data Protection, (Cyber)security and AI Testimonial

We have advised a medical device manufacturer on collaborations with academic institutions on data collection for training of AI systems, including the necessary data protection contracts.

Digital Health Medical Devices Data Protection, (Cyber)security and AI Testimonial

We have assisted a medical device manufacturer in ensuring that their SAAS-application complies with the Data Act and the GDPR.

Healthcare Medical Devices Pharmaceuticals Data Protection, (Cyber)security and AI Testimonial

What distinguishes our lawyers is the ability to see the whole regulatory picture. We have assisted multiple clients, ranging from CROs to pharma start-ups to medical device manufacturers, in setting up GDPR compliance processes and agreements that allow for seamless interaction with other legal frameworks such as MDR and IVDR.

Digital Health Data Protection, (Cyber)security and AI Regulatory Compliance and Enforcement Testimonial

We have advised a telehealth provider on its data processing strategy in connection with the roll-out of a new digital platform, including advising on cross-border data exchange requirements for the provision of digital healthcare services.

Chemicals Regulatory Compliance and Enforcement Spin-out and Starter Advisory Testimonial

We have advised a start-up on the legal limitations and requirements related to the transport of dangerous substances.

Healthcare Data Protection, (Cyber)security and AI Testimonial

We have advised a healthcare institution on the conditions under which medical professional secrecy may be breached.

Biotech Corporate, Governance and Boardroom Counselling Intellectual Property and Licensing Spin-out and Starter Advisory Testimonial

Axon regularly advises spin-outs from academic institutions on a wide range of topics. We make sure that the spin-out’s license agreement includes commercially and legally viable terms and is attractive to investors. In addition, we advise on the corporate structure of the spin-out, balancing the interest of the founders, the academic institution and all other stakeholders.